DNA Oestrogen

(Includes 12 gene variants involved in oestrogen biosynthesis, oestrogen metabolism, and phase 1 and phase II detoxification)

Approximately 80% of breast cancer occurs in women with little to no family history. Research has shown that an increased lifetime exposure to oestrogen, and unbalanced oestrogen metabolism, is a strong risk factor in the development of breast, ovarian and prostate cancer, as well as oestrogen dominant disorders, such as endometriosis and premenstrual syndrome.

Clinical value

Can be viewed as a ‘foundation to health’ test and is therefore appropriate for any individual seeking to improve their health outcomes, be it those who already suffer health complaints such as chronic fatigue, gut issues, cardiovascular disease, or insulin resistance, or those who are concerned about a family history of a chronic disease of lifestyle. The test is also valuable for those who would like to optimise health outcomes and refine their health routine with a targeted approach to diet, lifestyle and nutraceuticals

The report provides

• Women or men with a strong family history of breast, ovarian, colon or prostate cancer
• Women who suffer from oestrogen-dominant conditions such as endometriosis, premenstrual syndrome, and uterine fibroid tumours
• Women considering oral contraceptives, hormone replacement therapy or bio-identical hormone supplementation
• Women who are considering in vitro fertilisation or who have been diagnosed with oestrogen receptor-positive breast cancer

Assessment of

• 10 genes involved in:
• Oestrogen metabolism
• Phase I and phase II detoxification
• Factor V
• Oestrogen hormones

Sample Report

https://cdn.shopify.com/s/files/1/2660/5186/files/DNAOestrogen_Sample_Report.pdf?v=1727994964